|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent Orthofix Medical insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why Orthofix Medical insider buys are important for investors to follow.
Date | Insider | Price | Amount |
9-14-2023 Insider Buy |
James F. Hinrichs Director |
$13.47
CAGR »
|
$101,025.00 7,500 shares |
11-19-2021 Insider Buy |
Rice Doug CFO |
$30.05
CAGR »
|
$42,070.00 1,400 shares |
11-18-2021 Insider Buy |
Kimberley A. Elting Chief Legal & Develop. Officer |
$30.34
CAGR »
|
$30,340.00 1,000 shares |
11-18-2021 Insider Buy |
Jon Carl Serbousek CEO |
$31.14
CAGR »
|
$52,003.80 1,670 shares |
3-16-2020 Insider Buy |
Ronald A. Matricaria Director |
$24.25
CAGR »
|
$485,000.00 20,000 shares |
2-27-2020 Insider Buy |
Jon Carl Serbousek CEO |
$35.48
CAGR »
|
$102,895.48 2,900 shares |
10-31-2019 Insider Buy |
Ronald A. Matricaria Director |
$42.27
CAGR »
|
$845,305.00 20,000 shares |
5-3-2018 Insider Buy |
Ronald A. Matricaria Director |
$51.97
CAGR »
|
$519,724.00 10,000 shares |
6-2-2015 Insider Buy |
Ronald A. Matricaria Director |
$32.65
CAGR »
|
$1,632,521.52 50,000 shares |
6-10-2014 Insider Buy |
Mark A. Heggestad Chief Financial Officer |
$33.25
CAGR »
|
$455,453.63 13,696 shares |
5-20-2013 Insider Buy |
Emily Buxton Chief Financial Officer |
$26.52
CAGR »
|
$19,890.00 750 shares |
5-17-2013 Insider Buy |
Brad Mason President and CEO |
$26.45
CAGR »
|
$132,258.00 5,000 shares |
5-17-2013 Insider Buy |
Kenneth R. Weisshaar Director |
$26.40
CAGR »
|
$26,395.70 1,000 shares |
5-14-2013 Insider Buy |
Michael Mainelli Director |
$26.36
CAGR »
|
$13,179.05 500 shares |
5-14-2013 Insider Buy |
James Gero Director |
$26.37
CAGR »
|
$527,444.00 20,000 shares |
2-27-2013 Insider Buy |
Robert S. Vaters President and CEO |
$35.97
CAGR »
|
$107,910.00 3,000 shares |
11-22-2010 Insider Buy |
Michael Mainelli Director |
$26.73
CAGR »
|
$13,364.95 500 shares |
11-8-2010 Insider Buy |
Alan Milinazzo President & CEO |
$26.59
CAGR »
|
$29,249.00 1,100 shares |
Also See: Institutional Holders of OFIX
Also See: SEC filings
Below we present the annualized performance delivered by Orthofix Medical stock since 9-14-2023 (the date of the most recent
insider purchase). The performance of the investment from the time Orthofix Medical insider buying occurred is the ultimate
test of whether insiders were right about OFIX being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
09/15/2023 |
|
End date: |
05/01/2024 |
|
Start price/share: |
$13.03 |
|
End price/share: |
$13.03 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
0.00% |
|
Annualized Gain: |
0.00% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$10,000.00 |
|
Years: |
0.63 |
|
Orthofix Medical Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent Orthofix Medical insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding OFIX
|
|